ER-CHOP Promising for Diffuse Large B-Cell NHL (03-8-2009)

ER-CHOP Promising for Diffuse Large B-Cell NHL The treatment combination consisting of epratuzumab, Rituxan® (rituximab), and the chemotherapy combination referred to as CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) provides high... Continue Reading

Zevalin® Effective for Treatment of Cutaneous B-Cell Lymphoma (03-8-2009)

Zevalin® Effective for Treatment of Cutaneous B-Cell Lymphoma Zevalin® (Yttrium-90 [(90)Y] ibritumomab tiuxetan) appears highly effective in the treatment of primary cutaneous B-cell lymphoma (PCBCL). The details of this study appeared in an early online... Continue Reading

Treanda® plus Rituxan® Effective for Recurrent Non-Hodgkin’s Lymphoma (03-8-2009)

Treanda® plus Rituxan® Effective for Recurrent Non-Hodgkin’s Lymphoma The treatment combination consisting of Treanda® (bendamustine) plus Rituxan® (rituximab) provides effective therapy for patients with non-Hodgkin’s lymphoma (NHL) that... Continue Reading

Smoking and Heavy Alcohol Consumption Reduce Survival in Non-Hodgkin’s Lymphoma (03-8-2009)

Smoking and Heavy Alcohol Consumption Reduce Survival in Non-Hodgkin’s Lymphoma Patients diagnosed with non-Hodgkin’s lymphoma (NHL) who smoke tobacco products and/or drink large quantities of alcohol have a reduced chance of optimal survival.... Continue Reading

Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma (03-8-2009)

Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma Statins may reduce the effectiveness of Rituxan® (rituximab) in treatment of non-Hodgkin’s lymphoma (NHL), according to a recently published article in PLoS Med (the... Continue Reading

Worse Prognosis for “Bulky” Disease Diffuse Large B-Cell Lymphoma (03-8-2009)

Worse Prognosis for “Bulky” Disease Diffuse Large B-Cell Lymphoma Young patients with diffuse large-B-cell lymphoma (DLBCL) with cancerous masses that are 10.0 centimeters or greater in diameter are considered to have “bulky” disease... Continue Reading

Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas (03-8-2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies... Continue Reading

The American Society of Clinical Oncology 2008: Advances in Treatment of Lymphoma and Chronic Lymphocytic Leukemia (03-8-2009)

The American Society of Clinical Oncology 2008: Advances in Treatment of Lymphoma and Chronic Lymphocytic Leukemia At the 2008 meeting of the American Society of Clinical Oncology (ASCO), there were more than 100 abstracts devoted to the treatment of... Continue Reading

Survival Rates Improving in Childhood Hematologic Cancers (09-29-2008)

Survival Rates Improving in Childhood Hematologic Cancers Five- and 10-year survival rates in childhood hematalogic cancers have significantly improved since 1990, according to the results of a study recently published in the Journal of the National Cancer... Continue Reading

Supportive Care and Hematologic Malignancies (01-21-2008)

Supportive Care and Hematologic Malignancies: A Report from the 2007 American Society of Hematology (ASH) Meeting Introduction At the 2007 meeting of the American Society of Hematology (ASH) the most interesting supportive care studies involved second... Continue Reading